NCT03669627 CT18 Infant Influenza Priming Study in Vaccine Naive Infants Status COMPLETED Phase PHASE2
NCT03653364 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms Status COMPLETED Phase PHASE3
NCT03629184 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms Status COMPLETED Phase PHASE3
NCT03617523 Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations Status COMPLETED Phase PHASE4
NCT03603509 Gene Signatures of Influenza Vaccine Responses in Older Adults Status COMPLETED Phase PHASE4
NCT03595358 Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction Status COMPLETED Phase NA
NCT03594890 Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03590808 Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor Status COMPLETED Phase NA
NCT03581903 A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine Status COMPLETED Phase PHASE1
NCT03546192 Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route) Status COMPLETED Phase PHASE4
NCT03474887 Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care Status COMPLETED Phase N/A
NCT03459391 Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03455491 Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections Status COMPLETED Phase PHASE2